| 1 |
34532909 | High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women. | 2022 Feb |
1 |
| 2 |
25968950 | Aldehyde adducts generated during lipid peroxidation modification of proteins. | 2015 |
1 |
| 3 |
26425439 | Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction. | 2015 |
1 |
| 4 |
19150065 | Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions. | 2009 Jul |
2 |
| 5 |
19393338 | Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells. | 2009 Aug |
1 |
| 6 |
18483467 | A lipid-derived endogenous inducer of COX-2: a bridge between inflammation and oxidative stress. | 2008 May 31 |
1 |
| 7 |
16677655 | Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100. | 2007 Feb |
1 |
| 8 |
17363723 | Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease. | 2007 May |
3 |
| 9 |
17364956 | Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome. | 2007 Mar |
2 |
| 10 |
15831809 | Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques. | 2005 Jun |
2 |
| 11 |
15451805 | Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. | 2004 Oct 5 |
3 |
| 12 |
15529550 | Oxidized LDL and coronary heart disease. | 2004 Oct |
1 |
| 13 |
12649091 | Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease. | 2003 May 1 |
4 |
| 14 |
12663661 | Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis. | 2003 Jun 6 |
3 |
| 15 |
12919321 | Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles. | 2003 Sep |
1 |
| 16 |
14670006 | Protein hydroperoxides are a major product of low density lipoprotein oxidation during copper, peroxyl radical and macrophage-mediated oxidation. | 2003 Sep |
1 |
| 17 |
12146975 | The inhibition of microsomal triglyceride transfer protein activity in rat hepatoma cells promotes proteasomal and nonproteasomal degradation of apoprotein b100. | 2002 Aug 6 |
1 |
| 18 |
9890615 | Circulating antibodies recognizing oxidatively modified low-density lipoprotein in children. | 1999 Jan |
1 |
| 19 |
10608719 | Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease. | 1999 Nov |
1 |
| 20 |
15992113 | Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis. | 1999 May |
1 |
| 21 |
9922802 | Oxidative modification of low-density lipoproteins in atherothrombosis. | 1998 |
1 |
| 22 |
9562653 | Influence of natural antioxidants on in vitro lipoprotein oxidation. | 1997 Jan-Dec |
1 |
| 23 |
8697069 | [The relationship between 4-hydroxynonenal-derived epitopes on apolipoprotein B and coronary heart disease]. | 1995 Oct |
2 |
| 24 |
7692957 | Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). | 1993 Nov |
3 |
| 25 |
8221023 | Lipid peroxidation and its role in atherosclerosis. | 1993 Jul |
1 |
| 26 |
8299218 | Malondialdehyde adducts to, and fragmentation of, apolipoprotein B from human plasma. | 1993 Sep 17 |
1 |
| 27 |
1450582 | Inhibition of LDL oxidation by antioxidants. | 1992 |
1 |